Viability of sham litigation suits on the line in AbbVie appeal
The award of $448 million in antitrust damages against the company in case brought by the Federal Trade Commission is also at stake.
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10